Citation Tools

Download PDFPDF

P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma
Free

Download to a citation manager

Cite this article as:
Maio M, Carlino M, Joshua A, et al
P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma